The association between tumour progression and vascularity in the oral mucosa.
Tumourigenesis in experimental models is associated with the formation of new blood vessels (angiogenesis). Recent studies have suggested that tumour angiogenic activity may be inferred in histological sections by measuring the density of the vasculature. The purpose of this study was to determine whether the transition from normal to dysplastic and neoplastic tissue in the oral mucosa is accompanied by quantitative or qualitative changes in the vascularity of the tissue, and how the estimate of vascularity is influenced by the vessel marker and method of assessment. A total of 100 specimens of normal oral mucosa, dysplastic lesions, and squamous cell carcinomas were examined. Sections were immunostained with the pan-endothelial antibodies to von Willebrand Factor (vWF) and CD31, or with an antibody to the alpha v beta 3 integrin, previously reported to be a marker of angiogenic vessels. Vascularity was quantitated by two different methods: highest microvascular density (h-MVD) and microvascular volume, as determined by point counting (MVV). The results showed that vascularity, measured by the MVV method using antibodies to either vWF or CD31, increased significantly (P < 0.0001) with disease progression from normal oral mucosa, through mild, moderate, and severe dysplasia to early and late carcinoma (76 paraffin-embedded tissues examined). In contrast, h-MVD did not discriminate between dysplastic lesions and carcinoma. A similar percentage of the total vessel volume (MVV) and density (h-MVD) were positive for alpha v beta 3 in 24 frozen tissues examined, including normal oral mucosa. It is concluded that there is a close association between vascularity and tumour progression in the oral mucosa. Morphometric analysis reflecting microvascular volume is more informative than the currently popular analysis of microvascular density. The expression of alpha v beta 3 in the vasculature of oral tissues does not necessarily reflect the presence of angiogenic vessels.
Pazouki
S
S
Department of Dental Surgery and Periodontology, Dental School, University of Dundee, U.K.
Chisholm
D M
DM
Adi
M M
MM
Carmichael
G
G
Farquharson
M
M
Ogden
G R
GR
Schor
S L
SL
Schor
A M
AM
D002294:Carcinoma, Squamous Cell / Q000098:blood supply*; D018450:Disease Progression; D006801:Humans; D007124:Immunoenzyme Techniques; D009061:Mouth Mucosa / Q000098:blood supply*; D009062:Mouth Neoplasms / Q000098:blood supply*; D009389:Neovascularization, Pathologic / Q000378:metabolism / Q000473:pathology*; D019408:Platelet Endothelial Cell Adhesion Molecule-1 / Q000378:metabolism; D011230:Precancerous Conditions / Q000098:blood supply*; D019030:Receptors, Vitronectin / Q000378:metabolism; D012039:Regional Blood Flow; D012189:Retrospective Studies; D014841:von Willebrand Factor / Q000378:metabolism
D019408:Platelet Endothelial Cell Adhesion Molecule-1; D019030:Receptors, Vitronectin; D014841:von Willebrand Factor